Derakhshani et al. have used single-cell RNA-seq data to evaluate the CTLA-4 gene expression in different PBMC cell types of patients with MS and they showed that CTLA-4 has a substantial expression in the naïve T cells, Tregs, and activated CD8+ T cells [86]. This evidence concerns the gene CD8A and myeloid sarcoma.